Bioinformatics News Aug 2008: bioinformatics, genomics, proteomics, microarray, etc.

Previous 1 2 3 4 Next

Luminex Corporation Reports Second Quarter 2008 Results
AUSTIN, Texas----Luminex Corporation today announced financial results for the second quarter and six months ended June 30, 2008. Financial and operating highlights include the following: Consolidated total revenue of $24.3 million, a 38.7 percent increase year-over-year System shipments of 203 resulting in cumulative shipments to date of 5,402, up 19.4 percent from a year ago; representing the ... (Thu, 07 Aug 2008 20:01:00 GMT)

Luminex Corporation Reports Second Quarter 2008 Results
Luminex Corporation (NASDAQ:LMNX) today announced financial results for the second quarter and six months ended June 30, 2008. Financial and operating highlights include the following: (Thu, 07 Aug 2008 20:26:34 GMT)

EXACT Sciences Announces Second Quarter 2008 Financial Results
EXACT Sciences Corporation (4592;NASDAQ:EXAS) announced today financial results for the second quarter (Thu, 07 Aug 2008 20:41:10 GMT)

Gene For Sexual Switching In Melons Provides Clues To Evolution Of Sex
A newly discovered function for a hormone in melons suggests it plays a role in how sexual systems evolve in plants. The finding offers new insights into the molecular basis for sex determination. (Thu, 07 Aug 2008 23:17:51 GMT)

Fuel From Bacteria Is One Step Closer
Scientists have shown how bacteria could be used as a future fuel. The research, published in the journal Bioinformatics, could have significant implications for the environment and the way we produce sustainable fuels in the future. (Thu, 07 Aug 2008 23:18:11 GMT)

Mutation Found In Dachshund Gene May Help Develop Therapies For Humans With Blindness
Cone-rod dystrophies (CRDs) are a group of eye diseases caused by progressive loss of the photoreceptor cells in the retina. In a study published online in Genome Research , researchers have identified a novel mutation in a gene associated with CRD in dogs, raising hopes that potential therapies can be developed for people suffering from these eye disorders. (Fri, 08 Aug 2008 01:01:50 GMT)

Scientists Challenge FBI to Release Data in U.S. Anthrax Probe
Aug. 8 (Bloomberg) -- Scientists challenged the FBI and prosecutors to share more data to back their allegation that an Army bioweapons expert worked alone to kill five people who handled anthrax-laced letters he put in the U.S. mail. (Fri, 08 Aug 2008 04:01:00 GMT)

New project targets sport doping cheats
Scientists at The University of Queensland and Macquarie University, Sydney have received almost $360,000 Federal Government funding to explore novel approaches to detect Growth Hormone drug cheats in elite sports. (Fri, 08 Aug 2008 05:13:22 GMT)

Strong revenue growth and sharp improvement of net result for Galapagos in 1H 2008
Click here to access the live audio webcast presentation at 14.00 CET/8:00 AM EST, call number +32.2.404.03.34 (Fri, 08 Aug 2008 06:07:00 GMT)

MIT Files Patent Suit Against Biotech Company Affymetrix
By Joyce Kwan STAFF REPORTER MIT filed a lawsuit against biotechnology company Affymetrix last month, alleging the company’s GeneChip technology infringes an existing MIT patent. (Fri, 08 Aug 2008 09:07:08 GMT)

Special Issue Celebrates 40 Years Of Drug Testing At The Olympics
It is almost exactly 40 years since drug tests were first conducted at the Olympic Games. Now they are an unfortunate but essential facet of the Games. Scientific advances, and advances in mass spectrometry in particular, have enabled the authorities to keep pace with attempts by drug cheats to avoid detection. (Fri, 08 Aug 2008 09:19:31 GMT)

CombiMatrix to Present At Noble Financial Equity Conference
MUKILTEO, Wash., Aug. 8, 2008 -- CombiMatrix Corporation announced today that Amit Kumar, Ph.D., President and Chief Executive Officer will present at the Fourth Annual Noble Financial Equity Conference at 1:00 p.m. on Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada. (Fri, 08 Aug 2008 10:00:00 GMT)

My Pharmiweb.com
AnaSpec Introduces New SensoLyte™ 570 Generic MMP Assay Kit with Industry’s Highest Wavelength AnaSpec Inc. Posted on:08 Aug 08 Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. (Fri, 08 Aug 2008 10:13:51 GMT)

AnaSpec Introduces New SensoLyte™ 570 Generic MMP Assay Kit With Industry's Highest Wavelength
Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion as well as other diseases is well known. AnaSpec has introduced the SensoLyteTM 570 Generic MMP Assay Kit, offering the industry's highest emission wavelength for MMP detection. (Fri, 08 Aug 2008 10:18:11 GMT)

EXACT Sciences Announces Next Generation Stool-based DNA Technology Study Results of 92% for Colorectal Cancer Detection
MARLBOROUGH, Mass.----EXACT Sciences Corporation today announced the published results of a study in which stool and blood plasma were assessed, in a head-to-head comparison, for the detection of colorectal cancer . (Fri, 08 Aug 2008 11:00:00 GMT)

EXACT Sciences Announces Next Generation Stool-based DNA Technology Study Results of 92% for Colorectal Cancer Detection
EXACT Sciences Corporation (NASDAQ: EXAS) today announced the published results of a study in which stool and blood plasma were assessed, in a head-to-head comparison, for the detection of colorectal cancer (CRC). Using an improved BEAMing DNA detection technology from Johns Hopkins University, study results demonstrated 92 percent sensitivity for detecting CRC in stool samples. Importantly, ... (Fri, 08 Aug 2008 11:24:42 GMT)

Fuel from bacteria just a step closer
Washington, Aug 8 : Scientists have mapped metabolism of a bacteria called Nostoc, which fixes nitrogen and releases hydrogen, possibly bringing sustainable fuel from microbes one step closer to reality. (Fri, 08 Aug 2008 11:30:13 GMT)

A Gene For Sexual Switching In Melons Provides Clues To The Evolution Of Sex
A newly discovered function for a hormone in melons suggests it plays a role in how sexual systems evolve in plants. The study, conducted by French and American scientists, appears in the latest issue of the journal Science. (Fri, 08 Aug 2008 12:03:21 GMT)

UGA gets grants to study biofuels
The University of Georgia has pulled in two federal grants worth $2.5 million to investigate biofuel production from switchgrass and sunflowers. (Fri, 08 Aug 2008 12:59:08 GMT)

NIH Chemical Genomics Program Extends Simulations Plus License
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 08 Aug 2008 14:09:42 GMT)

One-stop Shop For Minimal Information Standards
International communities of life scientists are merging efforts to create an initiative for harmonizing minimal information standards in biology. Data standards are increasingly vital to scientific progress, as groups from around the world look to share their data and mine it more effectively. (Fri, 08 Aug 2008 14:15:51 GMT)

Luminex Corporation to Present at Canaccord Adams Global Growth Conference
Luminex Corporation (NASDAQ:LMNX) today announced that management will present at the Canaccord Adams 28th Annual Global Growth Conference to be held August 12-14, 2008, in Boston. (Fri, 08 Aug 2008 15:24:42 GMT)

A one-stop shop for minimal information standards
More than 20 grass-roots standardisation groups, led by scientists at the European Bioinformatics Institute (EMBL-EBI) and the Centre for Ecology & Hydrology (CEH), have combined forces to form the "Minimum Information about a Biomedical or Biological Investigation" (MIBBI) initiative (www.mibbi.org). Their aim is to harmonise standards for high-throughput biology, and their methodology is ... (Fri, 08 Aug 2008 15:28:17 GMT)

Bacteria might some day be fuel producers
SHEFFIELD, England, Aug. 8 (UPI) -- Scientists at Britain's University of Sheffield say they've used mathematical computer models to show how bacteria might become a future source for fuels. (Fri, 08 Aug 2008 16:09:52 GMT)

NanoVector virus may solve nanoparticle drug delivery problems
RALEIGH, NC—North Carolina State University biological chemistry professor Stefan Franzen first learned about a distinctive plant virus when he met his colleague Steven Lommel over a beer in Poland several years ago. (Fri, 08 Aug 2008 16:23:08 GMT)

Bacteria might some day be fuel producers
Scientists at Britain's University of Sheffield say they've used mathematical computer models to show how bacteria might become a future source for fuels.The researchers mapped the metabolism of Nostoc, a bacterium that fixes nitrogen and, in doing so, releases hydrogen that can potentially be used as fuel.The research uncovered a previously unknown link between the energy machinery of the ... (Fri, 08 Aug 2008 16:32:00 GMT)

Software to improve AIDS survival?
As you all know, there are more than 33 million people living with AIDS worldwide. No cure or vaccine has been unveiled this week in Mexico during the International AIDS Conference. Still, European researchers have developed a predictive software system for HIV that could help extend the lives of victims... (Fri, 08 Aug 2008 17:43:45 GMT)

Bayer CropScience Licenses Ariadne, Integrated Genomics Databases
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 08 Aug 2008 20:10:12 GMT)

Rockville, Marylant August 8, 2008 Ariadne today announced that Bayer CropScience AG
has licensed its Pathway Studio platform with the ResNet® Plant database to supplement their plant stress reactions research. In particular, the company will use Pathway Studio for gene expression analysis of Plant and Fungi data. (Fri, 08 Aug 2008 20:52:01 GMT)

The panelists:
Nathan Feltman , Indiana secretary of commerce and CEO of the Indiana Economic Development Corp. (Sat, 09 Aug 2008 06:04:51 GMT)

A Necessary Compromise
In the spring of 1979, the Soviet city of Sverdlovsk (now Ekaterinburg) experienced a deadly outbreak of anthrax. The United States and other countries suspected that the disease was connected with clandestine biological warfare activities—a charge that the Soviets, not surprisingly, denied. (Sat, 09 Aug 2008 12:42:19 GMT)

What Your Child's DNA Can Tell You About Parenting
DNA discoveries are revealing why even the best parenting doesn't have the effects experts promise, from breast-feeding to letting kids learn from mistakes. (Sat, 09 Aug 2008 20:42:06 GMT)

At college
Matthew J. Brown, formerly of Freetown, graduated cum laude from the University of Rochester, N.Y., at a ceremony on May 18. He received a bachelor's degree in molecular genetics. (Sun, 10 Aug 2008 05:10:26 GMT)

DOE, USDA announce more than $10 million in bioenergy plant feedstock research
Agriculture Under Secretary for Research, Education and Economics Gale Buchanan and Energy Department Under Secretary for Science Raymond Orbach and July 31 announced plans to award 10 grants totaling more than $10 million to accelerate fundamental research in the development of cellulosic biofuels. (Sun, 10 Aug 2008 08:50:08 GMT)

HudsonAlpha's Myers embraces community
Rick Myers, hired by the HudsonAlpha Institute for Biotechnology with great fanfare almost a year ago, just completed his first month in Huntsville as full-time institute director. (Sun, 10 Aug 2008 09:27:04 GMT)

University researchers recognised
Senior lecturers in fields as diverse as management and microbiology have received University of Otago awards for the excellence of their research. (Sun, 10 Aug 2008 17:27:45 GMT)

Captchas are easily hackable
THERE WERE TWO talks on Captchas at Defcon 16, and they both said the same thing, Captchas are pointless and stupid. This was backed up with a lot of science and code, but the end result is the same, if you have a clue and some time, you can break them on a whim . (Sun, 10 Aug 2008 18:31:56 GMT)

Semen Proteomics Sheds Light on Loyalty and Evolution
Most people would be appalled to find a fly in their soup, but Drosophila researchers at the University of Washington are studying the soup in their flies. (Mon, 11 Aug 2008 02:00:20 GMT)

Genealogy Gets More Precise
Rapidly growing databases enable a more complete picture of one's ancestry. (Mon, 11 Aug 2008 04:29:24 GMT)

State-of-the-art facility focuses on bioinformatics
Fort Valley State University is preparing to provide the tools for one of its students to possibly find the cure to a terminal disease or identify future diseases. (Mon, 11 Aug 2008 07:10:17 GMT)

New Prostate Cancer Test Is Ready For Commercialization Following Successful Completion Of Final Clinical Trials
Health Discovery Corporation ("HDC") (OTCBB: HDVY) announced that HDC's new gene-based molecular diagnostic test for prostate cancer has now successfully completed it's Phase III double-blind clinical trial and is now ready for commercialization to be used by physicians on their patients at risk of having prostate cancer. (Mon, 11 Aug 2008 08:18:41 GMT)

Tumor Markers For Urothelial Carcinoma
UroToday.com - Despite continued downward trends of smoking incidence in the United States over the last decade, the incidence of bladder cancer continues to rise with an estimated 68,800 new cases expected to be diagnosed in 2008. The ratio of male to female incidence remains steady at 3:1 and, according to the SEER data in 2005, over 521,000 people have a history of bladder cancer in the US. (Mon, 11 Aug 2008 09:17:45 GMT)

EXACT Sciences Announces Next Generation Stool-Based DNA Technology Study Results Of 92% For Colorectal Cancer Detection
EXACT Sciences Corporation (NASDAQ: EXAS) announced the published results of a study in which stool and blood plasma were assessed, in a head-to-head comparison, for the detection of colorectal cancer (CRC). Using an improved BEAMing DNA detection technology from Johns Hopkins University, study results demonstrated 92 percent sensitivity for detecting CRC in stool samples. (Mon, 11 Aug 2008 09:20:18 GMT)

Clinical Data Reports Strong First Quarter Results
NEWTON, Mass.----Clinical Data, Inc. today announced strong results for the first fiscal quarter ended June 30, 2008. Total revenue for the first quarter rose 39% to $9.2 million from $6.6 million for the same period a year ago. (Mon, 11 Aug 2008 10:00:00 GMT)

Frost & Sullivan Lauds Helicos BioSciences' True Single-Molecule SequencingTM Platform
Based on its recent analysis of the genome/transcriptome sequencing market, Frost & Sullivan presents Helicos BioSciences Corporation (NASDAQ: HLCS) with the 2008 North American Frost & Sullivan Award for Technology Innovation of the Year. (Mon, 11 Aug 2008 10:18:46 GMT)

Health Discovery signs pact with PPI for monetization of patent portfolio
Health Discovery Corporation (HDC), a leader in support vector machine (SVM) based molecular diagnostic and prognostic test development, announced the signing of an agreement with Patent Profit International (PPI), a Silicon Valley-based patent brokerage firm, with the goal of exploiting the full monetization potential of HDC's extensive pioneering patent portfolio. (Mon, 11 Aug 2008 10:21:49 GMT)

Susan G. Komen for the Cure(R)'s Inaugural Promise Grant Announced: Multi-Million Dollar Pledge From American Airlines ...
Susan G. Komen for the Cure®, American Airlines and The University of Texas M. D. Anderson Cancer Center are targeting one of the most aggressive and elusive forms of breast cancer in a unique multi-million dollar partnership announced today. (Mon, 11 Aug 2008 12:00:00 GMT)

M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying ...
Rosetta Genomics, Ltd. , a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical validation study with The University of Texas M. D. (Mon, 11 Aug 2008 12:30:00 GMT)

HDC completes phase III trial on molecular diagnostic test for prostate cancer
Health Discovery Corporation (HDC) announced that HDC's new gene-based molecular diagnostic test for prostate cancer has now successfully completed its phase-III double-blind clinical trial and is now ready for commercialization to be used by physicians on their patients at risk of having prostate cancer. (Mon, 11 Aug 2008 12:50:38 GMT)

New Prostate Cancer Test to be Presented at Biomarker Discovery Europe 2008 Conference
SAVANNAH, Ga.----Health Discovery Corporation today announced that HDC's new gene-based molecular diagnostic test for prostate cancer which has now successfully completed its Phase III double-blind clinical trial and is now ready for commercialization, will be presented at the upcoming Biomarker Discovery Europe 2008 conference in Dublin, Ireland on October 2-3. (Mon, 11 Aug 2008 13:14:00 GMT)

Sports doping detection a never-ending science
As athletes flocked to Beijing to compete in the Summer Olympics, teams of scientists were already starting a round-the-clock marathon of drug testing to keep the Games free of illicit athletic enhancement. The experts are part of a passionate and growing... (Mon, 11 Aug 2008 14:39:46 GMT)

Large reservoir of mitochondrial DNA mutations identified in humans
Blacksburg, Va. – Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population. (Mon, 11 Aug 2008 14:39:59 GMT)

Advances in Science and Technology and the Chemical Weapons Convention
With the second review conference of the Chemical Weapons Convention (CWC) approaching in April, a raft of studies have appeared making clear that fundamental changes in science and technology are affecting the implementation of the treaty and that it must be adapted to take account of them.[ (Mon, 11 Aug 2008 14:42:54 GMT)

MD Anderson to Perform Clinical Validation Study for Rosetta Genomics' CUP Test
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 11 Aug 2008 14:55:02 GMT)

Large reservoir of mitochondrial DNA mutations identified in humans
Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population. Clinical analysis of blood samples from almost 3,000 infants born in north Cumbria, England, showed that at least 1 in 200 individuals in the general public harbor ... (Mon, 11 Aug 2008 14:58:37 GMT)

Nominations Open for 2009 Pezcoller Foundation-AACR International Award for Cancer Research
The American Association for Cancer Research (AACR) is currently accepting nominations for the prestigious Pezcoller Foundation-AACR International Award for Cancer Research. (Mon, 11 Aug 2008 15:26:09 GMT)

NASA Spaceline 11 July 2008 Current Space Life Science Awareness
NASA Spaceline 11 July 2008 Current Space Life Science Awareness (Mon, 11 Aug 2008 15:32:24 GMT)

Key to treating cancer may be finding its original cell
DURHAM, N.C. – Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity. (Mon, 11 Aug 2008 16:10:27 GMT)

Pfizer Animal Genetics & NBCEC Finding Links Between Genomics & Cattle Health Traits
NEW YORK, N.Y. (August 11, 2008)—A groundbreaking study at Colorado State University may lead to early identification of animals with less susceptibility to feedlot diseases, especially bovine respiratory disease (BRD). “This landmark research is providing us with greater insight into the genetic markers responsible for improved feedlot health, a promising significant breakthrough for the beef ... (Mon, 11 Aug 2008 18:13:48 GMT)

Scientists Characterize Immune Response, Inflammatory Gene in VEEV
A collaborative team of scientists from the Uniformed Services University of the Health Sciences (USU) and the Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration have characterized the immune response and inflammatory gene response in Venezuelan equine encephalitis virus (VEEV). (Mon, 11 Aug 2008 18:26:20 GMT)

Scientists discover reservoir of mitochondrial DNA mutations present in the general population
Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population. Clinical analysis of blood samples from almost 3,000 infants born in north Cumbria, England, showed that at least 1 in 200 individuals in the general public harbor ... (Mon, 11 Aug 2008 21:45:47 GMT)

More News
A Wisconsin biotechnology company is moving its headquarters to Gaithersburg and plans to expand from 30 to 80 employees within two years. (Mon, 11 Aug 2008 21:56:37 GMT)

Scottsdale Healthcare begins trials to improve muscle strength in cancer patients
Scottsdale Healthcare has launched a clinical trial studying patient response to a new medication for improving muscle strength in those with advanced cancer. (Mon, 11 Aug 2008 23:55:37 GMT)

Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment ...
Cell Therapeutics, Inc.'s subsidiary Systems Medicine announced today that planned enrollment is complete in the European Organization for Research and Treatment of Cancer randomized phase II clinical trial of brostallicin in patients with newly diagnosed advanced or metastatic soft tissue sarcoma who have had no prior chemotherapy. (Tue, 12 Aug 2008 05:30:00 GMT)

New Report Details Historic Mass Extinction Of Amphibians; Humans Worsen Spread Of Deadly Emerging Infectious Disease
Amphibians, reigning survivors of past mass extinctions, are sending a clear, unequivocal signal that something is wrong, as their extinction rates rise to unprecedented levels, according to a new paper. Humans are exacerbating two key natural threats: climate change and a deadly disease that is jumping from one species to another. (Tue, 12 Aug 2008 06:17:45 GMT)

Nominations Open For 2009 Pezcoller Foundation-AACR International Award For Cancer Research - Deadline For Nominations ...
The American Association for Cancer Research (AACR) is currently accepting nominations for the prestigious Pezcoller Foundation - AACR International Award for Cancer Research. (Tue, 12 Aug 2008 08:18:31 GMT)

My Pharmiweb.com
AnaSpec Introduces GO Peptides™ - Research-Ready Peptides On Demand AnaSpec Inc. Posted on:11 Aug 08 With the speed of research constantly accelerating, one of the major obstacles in peptide research is the length of time it takes to custom synthesize a peptide. (Tue, 12 Aug 2008 09:14:01 GMT)

M. D. Anderson To Initiate Clinical Validation Study On Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying ...
Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced the initiation of a clinical validation study with The University of Texas M. D. Anderson Cancer Center (MDACC). (Tue, 12 Aug 2008 09:17:45 GMT)

Caris Diagnostics Launches Target GI(TM) For Colon Cancer Patients
Caris Diagnostics (Caris Dx), a leading provider of the highest quality diagnostic, translational development and pharmaceutical services encompassing anatomic pathology and molecular testing, announced the offering of Target GI to physicians nationwide. (Tue, 12 Aug 2008 09:18:35 GMT)

CombiMatrix Announces Publication of Clinical Validation Study of the HemeScan Array for Chronic Lymphocytic Leukemia
MUKILTEO, Wash., Aug. 12, 2008 -- CombiMatrix Corporation announced today that a retrospective, clinical validation study of its test for Chronic Lymphocytic Leukemia is to be published in the September issue of the Journal of Molecular Diagnostics . (Tue, 12 Aug 2008 10:00:00 GMT)

Scientists Characterize Immune Response, Inflammatory Gene In VEEV
A collaborative team of scientists from the Uniformed Services University of the Health Sciences (USU) and the Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration have characterized the immune response and inflammatory gene response in Venezuelan equine encephalitis virus (VEEV). (Tue, 12 Aug 2008 10:17:10 GMT)

Large Reservoir Of Mitochondrial DNA Mutations Identified In Humans
Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population. (Tue, 12 Aug 2008 10:18:34 GMT)

Stellar Pharmaceuticals Inc. Announces Revenues Increased by 20.7% Gross Profits Up By 29.2%
Stellar Pharmaceuticals Inc.(OTC.BB: SLXCF) today announced that for the six month period ended June 30, 2008, total operating revenues improved by 20.7%. This improvement was driven by increased international sales for NeoVisc, while cost of products sold for the period improved to 23.5% of product sales compared to 27.8% of product sales in the same period in 2007. (Tue, 12 Aug 2008 11:30:00 GMT)

Geron and Exeter Life Sciences Merge Start Licensing and ViaGen to Form Combined Licensing and Operating Company for ...
Geron Corporation (Nasdaq:GERN) and Exeter Life Sciences, Inc. announced today the merger of Start Licensing, Inc. ("Start"), a joint venture between Geron and Exeter Life Sciences, and ViaGen, Inc., a subsidiary of Exeter Life Sciences. (Tue, 12 Aug 2008 11:55:03 GMT)

Geron, Exeter form company for animal cloning technologies
Geron Corp. and Exeter Life Sciences Inc. on Tuesday announced a combined company, Start Licensing Inc., which will manage and license a portfolio of intellectual property rights related to animal reproductive technologies such as animal cloning. (GERN) (Tue, 12 Aug 2008 13:00:46 GMT)

Isogen Biosolutions B.V. Is Now Ocimum Biosolutions B.V.
IJSSELSTEIN, Netherlands & HYDERABAD, India----Isogen Biosolutions B.V. has rebranded itself as Ocimum Biosolutions B.V. The aim of the rebranding exercise is to tap the emerging opportunities and need for globalized solutions in Genomics. (Tue, 12 Aug 2008 13:08:00 GMT)

Health Discovery Corporation's Newest U.S. Patent Covers SVM-Based Analysis of Medical Images
SAVANNAH, Ga.----Health Discovery Corporation today announced that the United States Patent and Trademark Office has granted Patent No. 7,383,237 on HDC’s claims covering the use of Support Vector Machines in computer-aided image analysis for analysis of digitized microscopic images of medical specimens. (Tue, 12 Aug 2008 13:10:00 GMT)

Health Discovery Corporation's Newest U.S. Patent Covers SVM-Based Analysis of Medical Images
Health Discovery Corporation ("HDC") (OTCBB: HDVY) today announced that the United States Patent and Trademark Office has granted Patent No. 7,383,237 on HDC's claims covering the use of Support Vector Machines (SVM's) in computer-aided image analysis for analysis of digitized microscopic images of medical specimens. This new patent is a continuation of HDC's Patent No. 6,996,549, which covers a ... (Tue, 12 Aug 2008 13:41:50 GMT)

Isogen Biosolutions B.V. Is Now Ocimum Biosolutions B.V.
Isogen Biosolutions B.V. has rebranded itself as Ocimum Biosolutions B.V. The aim of the rebranding exercise is to tap the emerging opportunities and need for globalized solutions in Genomics. This represents a significant milestone in company's history as the company hones its position as the premier integrated global genomics solutions provider. (Tue, 12 Aug 2008 13:42:10 GMT)

Large Reservoir Of Mitochondrial DNA Mutations Identified In Humans
Clinical analysis of blood samples from almost 3,000 infants showed that at least 1 in 200 individuals in the general public harbor mitochondrial DNA mutations that may lead to disease. (Tue, 12 Aug 2008 14:15:41 GMT)

My Pharmiweb.com
Isogen Biosolutions B.V. is now Ocimum Biosolutions B. V. Oligo, genomics, oligo design, microarray probes Posted on:12 Aug 08 Isogen Biosolutions B. V. has rebranded itself as Ocimum Biosolutions B. V. The aim of the rebranding exercise is to tap the emerging opportunities and need for globalized solutions in Genomics. (Tue, 12 Aug 2008 15:59:13 GMT)

Isogen Biosolutions B.V. is now Ocimum Biosolutions B. V.
IJsselstein (Netherlands)/ Hyderabad Aug 12: Isogen Biosolutions B. V. has rebranded itself as Ocimum Biosolutions B. V. The aim of the rebranding exercise is to tap the emerging opportunities and need for globalized solutions in Genomics. (Tue, 12 Aug 2008 17:29:50 GMT)

SRA Announces Financial Results for Fourth Quarter and Fiscal Year 2008
SRA International, Inc. , a leading provider of technology and strategic consulting services and solutions to government organizations, today announced operating results for the fourth quarter and fiscal year 2008, which ended June 30, 2008. (Tue, 12 Aug 2008 20:01:00 GMT)

Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
Rosetta Genomics , today announced it will release first quarter financial results on August 19, 2008, before the U.S. markets open. Rosetta Genomics will host a conference call with a simultaneous webcast to discuss these results at 8:30 a.m. (Tue, 12 Aug 2008 20:30:00 GMT)

Alpha Innotech Reports Second Quarter Profit on 17% Revenue Growth
Alpha Innotech Corp. (OTCBB:APNO), a leading provider of bioanalytical systems for drug discovery and life science research, today reported financial results for the quarter ending June 30, 2008. (Wed, 13 Aug 2008 01:09:43 GMT)

OU Robotics: Machines learning real-world problems
Robots doing tasks for someone with disabilities or managing large amounts of information for medical researchers? The stuff of sci-fi novels and the distant future? Maybe not so distant, students and faculty said last week at the University of Oklahoma. (Wed, 13 Aug 2008 04:02:28 GMT)

Chris Davis Buys Covidien Ltd., Brookfield Asset Management Inc. Ltd., Staples Inc., Sells CVS Caremark Corp., ...
Like many other value investors, Chris Davis's funds have been not doing very well. But it seems that he is determined, and he is buying a lot of new stocks. These are his buys and sells during the second quarter. Chris Davis owns 336 stocks with a total value of $81.8 billion. (Wed, 13 Aug 2008 04:11:17 GMT)

Enrolment completed in EORTC's phase II trial of brostallicin for sarcoma
Cell Therapeutics, Inc.'s (CTI) subsidiary Systems Medicine (SM) announced that planned enrolment is complete in the European Organization for Research and Treatment of Cancer (EORTC) randomized phase-II clinical trial of brostallicin in patients with newly diagnosed advanced or metastatic soft tissue sarcoma who have had no prior chemotherapy. (Wed, 13 Aug 2008 07:50:32 GMT)

Humans Worsen Spread Of Deadly Emerging Infectious Disease Amongst Amphibians
Amphibians, reigning survivors of past mass extinctions, are sending a clear, unequivocal signal that something is wrong, as their extinction rates rise to unprecedented levels, according to a paper published by the Proceedings of the National Academy of Sciences (PNAS). (Wed, 13 Aug 2008 09:17:41 GMT)

My Pharmiweb.com
Biocore and AnaSpec Sign Distributor Agreement AnaSpec Inc. Posted on:12 Aug 08 AnaSpec and Biocore Pty Ltd today announced a non-exclusive distributor agreement that will allow Biocore Pty Ltd to distribute AnaSpecâ€™s catalog and custom products throughout Australia. (Wed, 13 Aug 2008 09:43:51 GMT)

Affymetrix Technology Helps Advance Schizophrenia Research
SANTA CLARA, Calif.----Affymetrix Inc. announced today that researchers around the world have used the Affymetrix Genome-Wide Human SNP Arrays 5.0 and 6.0 to uncover important links between copy number variations and schizophrenia. (Wed, 13 Aug 2008 12:00:00 GMT)

MDRNA, Inc. Lead Candidate Demonstrates In Vivo Efficacy against Seasonal and Pandemic Flu Strains
BOTHELL, Wash.----MDRNA, Inc. announced today positive in vivo efficacy data on its proprietary RNAi-based therapeutic for the treatment of multiple strains of influenza A virus in animal models. (Wed, 13 Aug 2008 12:00:00 GMT)

MDRNA, Inc. Lead Candidate Demonstrates In Vivo Efficacy against Seasonal and Pandemic Flu Strains
MDRNA, Inc. (Nasdaq: MRNA) announced today positive in vivo efficacy data on its proprietary RNAi-based therapeutic for the treatment of multiple strains of influenza A virus in animal models. The in vivo data were presented by Shaguna Seth, Ph.D., Associate Director at MDRNA, Inc., at the XIV International Congress of Virology in Istanbul, Turkey. (Wed, 13 Aug 2008 12:25:27 GMT)

Affymetrix Technology Helps Advance Schizophrenia Research
Affymetrix Inc. (Nasdaq:AFFX) announced today that researchers around the world have used the Affymetrix Genome-Wide Human SNP Arrays 5.0 and 6.0 to uncover important links between copy number variations (CNVs) and schizophrenia. Researchers from the United States, Europe and Asia published their findings in recent issues of Nature and Nature Genetics. (Wed, 13 Aug 2008 12:43:24 GMT)

Power3 Medical Products, Inc. Provides Progress Report - NuroPro(R) Clinical Validation Study of Serum Biomarkers for ...
Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company specializing in the development and commercialization of diagnostic tests for early detection of breast cancer and neurodegenerative diseases, is providing an interim status report of its international validation study of the company's NuroPro(R) blood serum biomarker test for Alzheimer's disease. (Wed, 13 Aug 2008 12:55:13 GMT)

Latest Stories
Agricultural Research Service (ARS) molecular biologist John Lippolis is delving into the dynamics of the dairy cow immune system. His work is resulting in the first close-up look at how immune system proteins help protect the cows, and how bacterial proteins fight back. (Wed, 13 Aug 2008 14:13:36 GMT)

BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
According to new research from BioInformatics, LLC -- the leading market research and consulting firm serving the life science industry -- service providers in the life science industry must innovate to find new ways to demonstrate customer value. (Wed, 13 Aug 2008 15:10:00 GMT)

Sky islands: metaphor or misnomer?
The term "sky islands" sounds intriguing, but it may be more lyrical than useful when discussing mammal distributions, according to new research from Eric Waltari of the Sackler Institute of Comparative Genomics at the American Museum of Natural History and Robert Guralnick from the University of Colorado at Boulder. (Wed, 13 Aug 2008 16:24:57 GMT)

In print
Advances in gene therapy could tempt some athletes to enhance their genetic makeup, leading some researchers to work on detection methods just in case. (Wed, 13 Aug 2008 16:32:44 GMT)

DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature
WALNUT CREEK, CA—Genomics is accelerating improvements for converting plant biomass into biofuel—as an alternative to fossil fuel for the nation's transportation needs, reports Eddy Rubin, Director of the U.S. Department of Energy Joint Genome Institute (DOE JGI), in the August 14 edition of the journal Nature . In "Genomics of cellulosic biofuels," Rubin lays out a path forward for how emerging ... (Wed, 13 Aug 2008 17:10:03 GMT)

DOE JGI Director highlights the genomics of plant-based biofuels in the journal Nature
Genomics is accelerating improvements for converting plant biomass into biofuel—as an alternative to fossil fuel for the nation's transportation needs, reports Eddy Rubin, Director of the U.S. Department of Energy Joint Genome Institute (DOE JGI), in the August 14 edition of the journal Nature. In "Genomics of cellulosic biofuels," Rubin lays out a path forward for how emerging genomic ... (Wed, 13 Aug 2008 17:59:57 GMT)

Genomics Of Plant-based Biofuels
Genomics is accelerating improvements for converting plant biomass into biofuel -- as an alternative to fossil fuel for the nation's transportation needs. Now researchers lay out a path forward for how emerging genomic technologies will contribute to a substantially different biofuels future as compared to the present corn-based ethanol industry -- and in part mitigate the food-versus-fuel ... (Wed, 13 Aug 2008 19:30:31 GMT)

JGI's Rubin Predicts Genomics Will Spur Biofuel Development
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 13 Aug 2008 19:39:32 GMT)

CombiMatrix Corporation Reports Second Quarter 2008 Financial Results
MUKILTEO, Wash., Aug. 13, 2008 -- CombiMatrix Corporation today reported its financial results for the three and six months ended June 30, 2008. Key highlights for the second quarter and through the date of this release include the following: (Wed, 13 Aug 2008 20:00:00 GMT)

Walnut Creek, California August 13, 2008 Genomics is accelerating improvements for converting plant biomass into ...
(DOE JGI), in the August 14 edition of the journal Nature. (Thu, 14 Aug 2008 02:37:29 GMT)

Ocimum Biosolutions Announces Genomic Pioneer Awards
IJSSELSTEIN, Netherlands & HYDERABAD, India----Ocimum Biosolutions has announced a first of its kind award that recognizes the trailblazing research innovations in the genomics space. (Thu, 14 Aug 2008 06:57:00 GMT)

JBNI Releases Atmen, an All Natural Herbal Formula for Sinus Allergies
JBNI, a recognized leader in the fields of cancer research, genetics, and proteomics, announced today the release of Atmen, an upper respiratory formula for allergies and sinus health. The release of this new formula was in response to JBNI users' demand for an upper respiratory formula for sinus allergies to complement the general herbal allergy and constant fatigue fighter Epstin. (Thu, 14 Aug 2008 07:01:00 GMT)

JBNI Launches Herbal Appetite Suppressant Lip Balm for Weight Loss
In response to steady requests from physicians and the public over the last two decades, JBNI released a lip balm today that safely and immediately curbs appetite upon application. (Thu, 14 Aug 2008 07:01:00 GMT)

5AM Solutions Named National Cancer Institute caBIG Support Service Provider
Collaboration with National Cancer Institute Cancer Centers Facilitates Data-Sharing Among Cancer Researchers (Thu, 14 Aug 2008 07:01:00 GMT)

Ocimum Biosolutions Announces Genomic Pioneer Awards
Ocimum Biosolutions has announced a first of its kind award that recognizes the trailblazing research innovations in the genomics space. The award would be known as the Genomic Pioneers Award. The purpose of the Genomic Pioneers Award is to recognize excellence and outstanding contribution to the field of genomics using integrated state-of-the-art approaches. (Thu, 14 Aug 2008 07:09:58 GMT)

Ocimum Biosolutions announces Genomic Pioneer Awards
Ijsselstein/Hyderabad, Aug 14 : Ocimum Biosolutions has announced a first of its kind award that recognizes the trailblazing research innovations in the genomics space. (Thu, 14 Aug 2008 10:31:50 GMT)

Opportunities and Challenges for Biotechnology Markets in Europe
HANNOVER, Germany----Within Europe the market for biotech products is evolving in different ways in different countries, and it is difficult to get an overall picture of the potential offered by individual national markets. (Thu, 14 Aug 2008 11:47:00 GMT)

febit and TGen Collaborate to Study New DNA Capture Method
febit and the Translational Genomics Research Institute today announced the formation of a collaboration in which TGen will evaluate Next-Generation-Sequencing equipment in conjunction with febit's proprietary Geniom® Microarray Technology. (Thu, 14 Aug 2008 12:00:00 GMT)

University of Toronto to Acquire Canada's Most Powerful Supercomputer From IBM
The University of Toronto's SciNet Consortium and IBM today announced an agreement to build Canada's most powerful and energy-efficient supercomputer. (Thu, 14 Aug 2008 12:30:00 GMT)

Johns Hopkins University and Axela Enter into Cardiac Research Agreement
TORONTO----Researchers from the Johns Hopkins University School of Medicine have entered into an agreement with Axela Inc. to use dotLab® technology in a clinical trial that evaluates circulating cardiac Troponin complexes directly in patient samples. (Thu, 14 Aug 2008 14:11:00 GMT)

Johns Hopkins University and Axela Enter into Cardiac Research Agreement
Researchers from the Johns Hopkins University School of Medicine have entered into an agreement with Axela Inc. to use dotLab(R) technology in a clinical trial that evaluates circulating cardiac Troponin complexes (cTn) directly in patient samples. Dr. Jennifer Van Eyk, Director of the Johns Hopkins NHLBI Proteomics Center (JHNBPC) in Baltimore, U.S.A., is the lead researcher for this trial. The ... (Thu, 14 Aug 2008 15:08:43 GMT)

Signature Genomic Laboratories Announces 2009 Microarray Conference
SPOKANE, Wash.----Signature Genomic Laboratories announced their 2009 Scientific Microarray Conference will be held June 19-20, 2009 in Spokane. (Thu, 14 Aug 2008 16:00:00 GMT)

Signature Genomic Laboratories Announces 2009 Microarray Conference
Signature Genomic Laboratories announced their 2009 Scientific Microarray Conference will be held June 19-20, 2009 in Spokane. (Thu, 14 Aug 2008 16:29:04 GMT)

Nanogen Merges Into French Diagnostics Firm
Molecular diagnostics maker Nanogen Inc. said Aug. 14 it would merge its operations into French diagnostics firm the Elitech Group in a deal valued at roughly $100 million. (Thu, 14 Aug 2008 23:05:44 GMT)

NHGRI Sets Aside $400K for Data Center to Study Progress of Minorities in Genomics
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 14 Aug 2008 23:26:09 GMT)

Even salmon females are picky about mates
When it comes to salmon sex, it isn't the fastest sperm that always wins the race, with New Zealand scientists discovering females have a say over who fertilizes their eggs, even after they have been deposited. (Fri, 15 Aug 2008 06:47:01 GMT)

Nanogen and Elitech planning to join forces
Nanogen, one of San Diego's older biotechnology companies, announced yesterday that it will merge with the Elitech Group, a privately owned diagnostics company based in Paris, in an all-stock transaction. (Fri, 15 Aug 2008 10:07:27 GMT)

Cancer signatures uncovered
( BioMed Central ) A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures. (Fri, 15 Aug 2008 14:39:07 GMT)

ARS produces online databases for maize, blueberries
Agricultural Research Service scientists and colleagues have produced several online bioinformatics resources to support plant breeders and other scientists who research genetic traits among plant species. (Fri, 15 Aug 2008 18:54:59 GMT)

IBM to build Canada's most powerful supercomputer
IBM is teaming with the University of Toronto to build what they say will be the most powerful supercomputer in Canada. (IBM) (Fri, 15 Aug 2008 19:12:42 GMT)

Waters to Integrate Proteomics Instruments with Proteome Software's Scaffold
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 15 Aug 2008 20:40:31 GMT)

PROFILE: Tonawanda boy, 12, learns all about biology
Pop quiz: define “gel electrophoresis.”How about “wolbachia” or a “polymerase chain reaction?” (Sat, 16 Aug 2008 03:11:16 GMT)

Canada to get world's first supercomputer outside the US
By Gurmukh Singh, Toronto,Aug 16 : Toronto university and the IBM have joined hands to build Canada's most powerful and energy- efficient supercomputer yet. (Sat, 16 Aug 2008 09:16:21 GMT)

Canada to get world's first supercomputer outside the US
Toronto university and the IBM have joined hands to build Canada's most powerful and energy- efficient supercomputer yet. (Sat, 16 Aug 2008 09:39:28 GMT)

Pine beetle expert here Wednesday
Researchers are developing ways to battle mountain pine beetles with their own genes. (Sat, 16 Aug 2008 12:10:11 GMT)

Canada to get world's first supercomputer outside the US
Toronto,Aug 16 (IANS) Toronto university and the IBM have joined hands to build Canada's most powerful and energy- efficient supercomputer yet. (Sat, 16 Aug 2008 19:43:44 GMT)

CTI Announces That The EORTC Completes Enrollment In Phase II Clinical Trial Of Brostallicin
Cell Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) subsidiary Systems Medicine (SM) has announced that planned enrollment is complete in the European Organization for Research and Treatment of Cancer (EORTC) randomized phase II clinical trial of brostallicin in patients with newly diagnosed advanced or metastatic soft tissue sarcoma who have had no prior chemotherapy. (Sat, 16 Aug 2008 21:13:11 GMT)

Fears over possible genetic profiling from birth
profiling in which humans will be categorised at birth according to health and likelihood of illness could lead to widespread discrimination by the government, the NHS, big business and insurance companies. (Sat, 16 Aug 2008 22:44:25 GMT)

Google, 10 years in: big, friendly giant or a greedy Goliath?
Eagerly they came - the young, the ambitious, the smartest of the smart. They queued impatiently and crowded into the rafters above Charlie's Cafe at the 'Googleplex', the curving glass and steel cathedral of the internet age. Finally, laptops snapped shut and the room hushed. It was time for Barack Obama to preach to the converted. 'There is something improbable about this gathering,' said ... (Sat, 16 Aug 2008 23:29:13 GMT)

Google, 10 years in: big, friendly giant or a greedy Goliath?
Has the cool baby grown up into a sinister corporate threat to privacy? David Smith reports (Sat, 16 Aug 2008 23:39:39 GMT)

Mummified arm from glacier identified
It took nine years of sleuthing and advanced DNA science to discover identity of plane crash victim. (Sun, 17 Aug 2008 00:53:22 GMT)

Mummified remains from 1948 plane crash identified
Nine years of sleuthing, advanced DNA science and cutting-edge forensic techniques have finally put a name to a mummified hand and arm found in an Alaska glacier. (Sun, 17 Aug 2008 04:17:56 GMT)

Mummified remains from 1948 plane crash identified
Sat, Aug 16, 2008 (9:33 p.m.) Nine years of sleuthing, advanced DNA science and cutting-edge forensic techniques have finally put a name to a mummified hand and arm found in an Alaska glacier. (Sun, 17 Aug 2008 04:37:48 GMT)

9 years of sleuthing put name to '48 crash victim
It took nine years of sleuthing and advanced DNA science and cutting-edge forensic techniques, but a mummified hand and arm found in an Alaska glacier have been identified. (Sun, 17 Aug 2008 07:32:55 GMT)

Google: gentle giant or greedy beast?
Environment, science & technology: Has the cool baby grown up into a sinister corporate threat to privacy? David Smith reports (Sun, 17 Aug 2008 09:24:00 GMT)

Johns Hopkins University And Axela Enter Into Cardiac Research Agreement
Researchers from the Johns Hopkins University School of Medicine have entered into an agreement with Axela Inc. to use dotLab® technology in a clinical trial that evaluates circulating cardiac Troponin complexes (cTn) directly in patient samples. Dr. Jennifer Van Eyk, Director of the Johns Hopkins NHLBI Proteomics Center (JHNBPC) in Baltimore, U.S.A., is the lead researcher for this trial. (Sun, 17 Aug 2008 10:15:41 GMT)

Honor Roll /
David J. Colligan is the newly elected chairman of the not-for-profit Buffalo Olmsted Parks Conservancy. Colligan joined the Conservancy board of trustees in 2002. He is also a member of the Erie Canal Harbor Development Corporation and a founding member of the Buffalo City Honors School Foundation. (Sun, 17 Aug 2008 10:54:51 GMT)

Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008
AMSTERDAM, The Netherlands----Bruker Daltonics today is showcasing several new high performance mass spectrometry products and applications for proteomics at the 7th HUPO World Congress 2008: maXis™ is the world's first high speed Ultra High Resolution TOF mass spectrometer platform, and truly represents a revolution in tandem mass spectrometry. maXis offers exceptional proteomics performance ... (Sun, 17 Aug 2008 11:00:00 GMT)

Previous 1 2 3 4 Next